-
Mesothelioma_Whole_Genomes
Study
EGAS00001000830
-
Primary_angiosarcoma_Whole_Genome_Sequencing
Study
EGAS00001000851
-
Normal brain controls for ICGC PedBrain DNA methylation sequencing
Study
EGAS00001000909
-
Skin Adenocarcinoma Genome Sequencing
Study
EGAS00001001052
-
Exome_sequencing_of_EBV_driven_lymphoma
Study
EGAS00001001021
-
Barcelona_kids_with_melanoma
Study
EGAS00001000733
-
CRISPR_screen_M14__NCI_H3122
Study
EGAS00001001060
-
Genetic_profiling_of_mucosal_melanoma
Study
EGAS00001001115
-
Leeds_Melanoma_Cohort
Study
EGAS00001001158
-
Anaplastic_Meningioma_V3__cancer_gene_panel
Study
EGAS00001001155
-
Discovery_of_resistance_mechanisms_to_the_BRAF_inhibitor_vemurafenib_in_metastatic_BRAF_mutant_melanoma
Study
EGAS00001000812
-
Whole genome and transcriptome analysis of anaplastic thyroid carcinoma
Study
EGAS00001001214
-
Anaplastic_Meningioma_WGS_X10
Study
EGAS00001000859
-
Mechanisms_of_patient_response_to_Dabrafenib_in_Melanoma
Study
EGAS00001000946
-
Cross-species genomics identifies TAF12, NFYC and RAD54L as novel choroid plexus carcinoma oncogenes
Study
EGAS00001000961
-
71 Whole-exome sequencing of Esophageal Squamous Cell Carcinoma on Chinese Patients
Study
EGAS00001001475
-
Glioblastoma_CRISPR_Screen
Study
EGAS00001001519
-
BAP1_sequence_of_uveal_melanoma_cell_lines
Study
EGAS00001001520
-
Genetic landscape of relapsed DLBCL
Study
EGAS00001001553
-
PSCP_mutation_analysis_in_hESCs
Study
EGAS00001001561
-
PSCP_bisulphite_analysis_in_hESCs
Study
EGAS00001001625
-
Melanoma_C32_ENU_resistance_to_Combination_Therapy
Study
EGAS00001001614
-
RNA_seq_analysis_of_transcriptome_variation_with_human_ESC_subclones
Study
EGAS00001001655
-
Melanoma_C32_ENU_Resistance_to_Single_Agent_Therapy
Study
EGAS00001001697
-
Onco-exaptation of an Endogenous Retroviral LTR Drives IRF5 Expression in Hodgkin Lymphoma
Study
EGAS00001001205